Fast-paced growth of the feature-rich devices with the underlying technical advancements allowing convenient and safer self-injections is anticipated to fuel market growth over the forecast period. Prefilled syringes help the healthcare practitioners in saving efforts and time while preparing the injection doses. Additionally, they help decrease the device-based and manual measuring errors and waste of active pharmacological ingredients while shifting solutions from vials to the syringe.
Advancement in the biopharmaceutical industry has direct positive impact on demand for the prefilled syringes as they aid minimize loss of potency though transferring biopharmaceuticals in the different containers. Some of biological drugs that are packed in prefilled syringes which include small, as well as large, particles such as monoclonal antibodies and antibody drug conjugates.
On the other hand, controlled production of the plastic syringes is challenging market growth. Contrary effects of the plastic products on environment are also restraining adoption of these devices. Though, major companies in field are trying to innovate advanced materials that can be recyclable, disposable, and appropriate for containing these injectable drugs. This factor is expected to augment market growth in near future.Segment Overview
The disposable segment led global market in 2019 and is estimated to remain dominant through forecast years owed to its varied applications. High inclination for patient safety has caused increased usage of the disposable devices in the homecare and hospitals settings. Moreover, the devices decrease contamination risks, which is projected to boost the demand.
However, reusable segment is anticipated to register fastest growth rate throughout the forecast period. Expansion of advanced auto-injectors, including VigiPen by VigiHealth, and i-Pen by Haselmeier AG has increased the segment growth.Regional Overview
Europe is presently dominating global market owing to the growing demand for the prefilled syringes in region. Moreover, robust presence of the major market players including Schott Group, Gerresheimer AG, and Owen Mumford Ltd. is further likely to help increase the region’s growth.
The European Board of Anesthesiology (EBA) recommends use of the prefilled syringes for anaesthesia. Growing number of the surgeries due to numerous factors and the faster approval processes by numerous regulatory authorities are factors predictable to drive Europe regional market.
The Asia Pacific market is anticipated to grow at lucrative CAGR during forecast period. Rapidly emerging economies, such as China and India, and availability of the untapped growth prospects are key factors fuelling the region’s expansion. Furthermore, large patient population and the growing prevalence of numerous chronic diseases are anticipated to fuel sector growth in the region.Competitor overview
Price discrimination approach and public awareness campaigns implemented by the Mylan N.V. for its EpiPen, a patent protected device, an epinephrine injection, is resulting in growth of anaphylaxis application segment.
Prefilled products aid as a great tool for the storage of vaccines and the other biotech drugs, which are mostly unstable and are more prone to change the properties while shifting from vials. Lately U.S. FDA approved the Auvi Q by Kaléo. The device is planned for use in the life-threatening allergic responses in children and infants. Some of key players in global market are Schott Group, Gerresheimer AG, Unilife Corporation, Owen Mumford, Nipro Medical Corporation, and Haselmeier AG. The companies focus on organising investments to rise their manufacturing competences and hence sustain their revenue share.Key Players
- Gerresheimer AG
- Schott Group
- Unilife Corporation
- Nipro Medical Corporation
- Owen Mumford
- Haselmeier AG
- Rheumatoid Arthritis
By Distribution Channel
- Mail Order Pharmacies
- Ambulatory Surgery Centers
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Rest of LAMEA